Zhang, Z., Zhang, Y., Chen, G., Hong, S., Yang, Y., Fang, W., … Zhang, L. (2018). Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis. The Oncologist. https://doi.org/10.1634/theoncologist.2017-0378 (Original work published 2018)

Liu, P., Chen, J., Zhang, Z., Xie, Z., Du, X., & Gu, Z. (2018). Bio-inspired robust non-iridescent structural color with self-adhesive amorphous colloidal particle arrays. Nanoscale. https://doi.org/10.1039/c7nr08056e (Original work published 2018)

Zhu, G., Wang, S., Huang, Z., Zhang, S., Liao, Q., Zhang, C., … Huang, S. (2018). Rewiring of the Fruit Metabolome in Tomato Breeding. Cell, 172(1-2), 249-261.e12. https://doi.org/10.1016/j.cell.2017.12.019 (Original work published 2018)

Bradley, L., Fuqua, J., Richardson, A., Turchan-Cholewo, J., Ai, Y., Kelps, K., … Gerhardt, G. (2010). Dopamine neuron stimulating actions of a GDNF propeptide. PloS One, 5(3), e9752. https://doi.org/10.1371/journal.pone.0009752 (Original work published 2010)

Hardy, P., Keeley, D., Schorn, G., Forman, E., Ai, Y., Venugopalan, R., … Bradley, L. (2013). Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine. Journal of Neuroscience Methods, 219(1), 169-75. https://doi.org/10.1016/j.jneumeth.2013.07.013 (Original work published 2013)

Zhang, S., Zhang, M., Jing, Y., Yin, X., Ma, P., Zhang, Z., … Zhuang, G. (2018). Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nature Communications, 9(1), 215. https://doi.org/10.1038/s41467-017-02693-9 (Original work published 2018)

Neugebauer, N., Zhang, Z., Crooks, P., Dwoskin, L., & Bardo, M. (2006). Effect of a novel nicotinic receptor antagonist, N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Psychopharmacology, 184(3-4), 426-34. https://doi.org/10.1007/s00213-005-0163-8

Rahman, S., Neugebauer, N., Zhang, Z., Crooks, P., Dwoskin, L., & Bardo, M. (2007). The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology, 52(3), 755-63. https://doi.org/10.1016/j.neuropharm.2006.09.012

Rahman, S., Zhang, Z., Papke, R., Crooks, P., Dwoskin, L., & Bardo, M. (2008). Region-specific effects of N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. British Journal of Pharmacology, 153(4), 792-804. https://doi.org/10.1038/sj.bjp.0707612

Dwoskin, L., Wooters, T., Sumithran, S., Siripurapu, K., Joyce, B., Lockman, P., … Bardo, M. (2008). N,N’-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630